Literature DB >> 16501055

The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation.

Salvatore Cuzzocrea1, Emanuela Mazzon, Rosanna Di Paola, Angelo Peli, Andrea Bonato, Domenico Britti, Tiziana Genovese, Carmelo Muià, Concetta Crisafulli, Achille P Caputi.   

Abstract

The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) is a member of the nuclear receptor superfamily of ligand-dependent transcription factors related to retinoid, steroid, and thyroid hormone receptors. The aim of the present study was to evaluate the role of the PPAR-alpha receptor on the development of acute inflammation. To address this question, we used two animal models of acute inflammation (carrageenan-induced paw edema and carrageenan-induced pleurisy). We report here that when compared with PPAR-alpha wild-type mice, PPAR-alpha knockout mice (PPAR-alphaKO) mice experienced a higher rate of the extent and severity when subjected to carrageenan injection in the paw edema model or to carrageenan administration in the pleurisy model. In particular, the absence of a functional PPAR-alpha gene in PPAR-alphaKO mice resulted in a significant augmentation of various inflammatory parameters (e.g., enhancement of paw edema, pleural exudate formation, mononuclear cell infiltration, and histological injury) in vivo. Furthermore, the absence of a functional PPAR-alpha gene enhanced the staining (immunohistochemistry) for FAS ligand in the paw and in the lung and the expression of tumor necrosis factor alpha and interleukin-1beta in the lungs of carrageenan-treated mice. In conclusion, the increased inflammatory response observed in PPAR-alphaKO mice strongly suggests that a PPAR-alpha pathway modulates the degree of acute inflammation in the mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501055     DOI: 10.1189/jlb.0605341

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  35 in total

1.  PPAR-alpha in cutaneous inflammation.

Authors:  Sandrine Dubrac; Matthias Schmuth
Journal:  Dermatoendocrinol       Date:  2011-01

2.  MicroRNA-409-5p promotes retinal neovascularization in diabetic retinopathy.

Authors:  Ying Wang; Wenwen Lin; Jianghua Ju
Journal:  Cell Cycle       Date:  2020-04-15       Impact factor: 4.534

3.  Rosiglitazone, peroxisome proliferator receptor-gamma agonist, ameliorates gentamicin-induced nephrotoxicity in rats.

Authors:  Emin Ozbek; Yusuf Ozlem Ilbey; Abdulmuttalip Simsek; Mustafa Cekmen; Fatih Mete; Adnan Somay
Journal:  Int Urol Nephrol       Date:  2009-09-25       Impact factor: 2.370

4.  Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study.

Authors:  Maria Galuppo; Rosanna Di Paola; Emanuela Mazzon; Tiziana Genovese; Concetta Crisafulli; Irene Paterniti; Elisabetta Cuzzocrea; Placido Bramanti; Amar Kapoor; Christoph Thiemermann; Salvatore Cuzzocrea
Journal:  J Inflamm (Lond)       Date:  2010-02-18       Impact factor: 4.981

5.  PPAR-alpha Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice.

Authors:  Emanuela Esposito; Emanuela Mazzon; Irene Paterniti; Roberto Dal Toso; Giovanna Pressi; Rocco Caminiti; Salvatore Cuzzocrea
Journal:  PPAR Res       Date:  2010-06-30       Impact factor: 4.964

6.  Fenofibrate Attenuates Neutrophilic Inflammation in Airway Epithelia: Potential Drug Repurposing for Cystic Fibrosis.

Authors:  Amanda J Stolarz; Ryan A Farris; Charla A Wiley; Catherine E O'Brien; Elvin T Price
Journal:  Clin Transl Sci       Date:  2015-08-10       Impact factor: 4.689

Review 7.  Ketogenic diets and pain.

Authors:  Susan A Masino; David N Ruskin
Journal:  J Child Neurol       Date:  2013-05-16       Impact factor: 1.987

Review 8.  Diabetes, insulin, and development of acute lung injury.

Authors:  Shyoko Honiden; Michelle N Gong
Journal:  Crit Care Med       Date:  2009-08       Impact factor: 7.598

Review 9.  Dynamic regulation of the endocannabinoid system: implications for analgesia.

Authors:  Devi Rani Sagar; A Gemma Gaw; Bright N Okine; Stephen G Woodhams; Amy Wong; David A Kendall; Victoria Chapman
Journal:  Mol Pain       Date:  2009-10-08       Impact factor: 3.395

10.  Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation.

Authors:  Concetta Crisafulli; Emanuela Mazzon; Irene Paterniti; Maria Galuppo; Placido Bramanti; Salvatore Cuzzocrea
Journal:  Respir Res       Date:  2010-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.